References
- Shanghai Municipal Center for Disease Control and Prevention scientific report. Tumor 2008;28:726.
- Lowenfels AB, Maisonneuve P. Epidemiology and risk factors for pancreatic cancer. Pract Res Clin Gastroenterol 2006; 20: 197–209
- Yeo CJ, Cameron JL. Pancreatic cancer. Curr Probl Surg 1999; 36: 59–152
- Burris HA, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial. J Clin Oncol 1997; 15: 2403–2413
- Moore MJ, Goldstein D, Hamm J, Figer A, Hecht JR, Gallinger S, Au HJ, Murawa P, Walde D, Wolff RA, et al. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 2007; 25: 1960–1966
- Wu F, Wang ZB, Chen WZ, Zou JZ, Bai J, Zhu H, Li KQ, Xie FL, Jin CB, Su HB, et al. Extracorporeal focused ultrasound surgery for treatment of human solid carcinomas: Early Chinese clinical experience. Ultrasound Med Biol 2004; 30: 245–260
- Wu F, Wang ZB, Zhu H, Chen WZ, Zou JZ, Bai J, Li KQ, Jin CB, Xie FL, Su HB. Feasibility of US guided high-intensity focused ultrasound treatment in patients with advanced pancreatic cancer: Initial experience. Radiol 2005; 236: 1034–1040
- Anderson KO, Syrjala KL, Cleeland CS. How to assess cancer pain. Handbook of Pain Assessment, DC Turk, R Melzack. Guilford Press, New York 2001; 579–600
- Pollock RE, Doroshow JH, Khayat D, Nakao A, O'sullivan B. UICC manual of clinical oncology, 8th. Wiley-Liss, Hoboken, NJ 2004
- Wu F, Chen WZ, Bai J, Zou JZ, Wang ZL, Zhu H, Wang ZB. Pathological changes in human malignant carcinoma treated with high-intensity focused ultrasound. Ultrasound Med Biol 2001; 27: 1099–1106
- Brescia FJ, Portenoy RK, Ryan M, Krasnoff L, Gray G. Pain, opioid use, and survival in hospitalized patients with advanced cancer. J Clin Oncol 1992; 10: 149–155
- Xie B, Ling JJ, Zhang WM, Huang XQ, Zhen JH, Huang YZ. The efficacy of high-intensity focused ultrasound (HIFU) in advanced pancreatic cancer. Clin Oncol Cancer Res 2008; 5: 183–186
- Zeng LQ, Wei AN, Fu H, Du YH, Wang YQ, Li ZY, Wang ZB. The ablative effect of high intensity focused ultrasound on the celiac ganglion in rabbits [in Chinese]. Chin J Anesthesiol 2006; 26: 425–427
- Rykowski JJ, Hilgier M. Efficacy of neurolytic celiac plexus block in varying locations of pancreatic cancer. Anesthesiol 2000; 92: 347–354
- Hidalgo M. Pancreatic cancer. N Engl J Med 2010; 362: 1605–1617
- Custodio A, Puente J, Sastre J, Díaz-Rubio E. Second-line therapy for advanced pancreatic cancer: A review of the literature and future directions. Cancer Treat Rev 2009; 35: 676–684
- Von-Wichert G, Seufferlein T, Adler G. Palliative treatment of pancreatic cancer. J Dig Dis 2008; 9: 1–7